Empowering mental health professionals with peer-reviewed psychiatric research and insights
Page 60
More JCP Articles
Original Research
Riluzole for Antidepressant-Resistant PTSD
October 27, 2020
Current pharmacologic treatments for posttraumatic stress disorder (PTSD) have shown limited efficacy. This study investigated the efficacy of the glutamatergic modulator riluzole for combat-related PTSD symptoms resistant to SSRIs…
Review Article
Psychological Responses of Health Care Workers Toward Infectious Disease Outbreaks: Implications for the COVID-19 Pandemic
October 20, 2020
When considering how to help health care workers cope with the effects of the COVID-19 crisis, what can be learned from the past? This review looked at psychological and…
Original Research
Effect of SPN-812 (Viloxazine Extended-Release) on QTc Interval
October 13, 2020
This double-blind, randomized, crossover study investigated the effects of a supratherapeutic dose of SPN-812, a drug currently under investigation as a treatment for ADHD, on cardiac repolarization (QTc) in…
Original Research
Medications for DSM-5 PTSD
October 13, 2020
This retrospective study explored whether 5 medications for PTSD with efficacy in meta-analyses of randomized controlled trials—fluoxetine, paroxetine, sertraline, topiramate, and venlafaxine—are also effective in routine clinical practice.
Original Research
Delirium-Preventive Effects of Suvorexant in Real-World Settings
October 6, 2020
Although previous studies have demonstrated the efficacy of suvorexant for delirium prevention in limited randomized clinical trial settings, this study aimed to examine the effects of suvorexant on delirium…
Brief Report
Passive Suicidal Ideation in the Early Stage of the COVID-19 Pandemic and Lockdown in a Spanish Sample
October 6, 2020
This study draws on an online survey conducted to determine the prevalence of passive suicidal ideation early in the COVID-19 pandemic in Spain. Read the report to learn about…
